Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NKQ-01 for cancer-related breakthrough pain
jRCT2080221212Phase 2
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of NKQ-01 in breakthrough pain, sponsored by Nippon Kayaku Co., Ltd.
02
Drugs
NKQ-01
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on jRCT2080221212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221212.